Murphy & Mullick Capital Management Corp Novo Nordisk A S Transaction History
Murphy & Mullick Capital Management Corp
- $103 Billion
- Q1 2025
A detailed history of Murphy & Mullick Capital Management Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 6,152 shares of NVO stock, worth $314,244. This represents 0.41% of its overall portfolio holdings.
Number of Shares
6,152
Previous 6,162
0.16%
Holding current value
$314,244
Previous $530 Million
19.41%
% of portfolio
0.41%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,742Shares Held
338MCall Options Held
10.9MPut Options Held
15.9M-
Jennison Associates LLC18.9MShares$965 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$756 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$633 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$629 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$606 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $115B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...